SHS Capital

ROTOP is a pharmaceutical company that develops and manufactures radiopharmaceuticals for diagnostics and therapy in nuclear medicine and molecular imaging. The company produces cGMP-compliant radiopharmaceuticals and offers API and precursor synthesis, analysis kit development, project management, and full regulatory support, including quality control and therapy services for PET and related applications. ROTOP also provides contract development and manufacturing operations (CDMO) services to enable efficient and effective diagnostics and therapy across drug development stages. Through its integrated services, ROTOP supports clients in bringing radiodiagnostics and radiotherapeutics from concept to clinical use.

Medical Technology Rostock supplies erection aids, compression, and electrotherapy devices.

Develco Pharma Schweiz is pharmaceutical manufacturing company produce formulations of drugs, health care, medicine.

Essert is a developer of robotic systems and augmented automation solutions aimed at driving digital transformation across various industries. The company specializes in modular and flexible robot workstations and human-robot collaboration systems. By providing digital management services, Essert enables electronic and other sectors to enhance productivity and improve the quality of their processes. The company fosters a culture of community and open communication, striving to set and achieve new sustainability goals in a technologically advanced environment.

CAM Bioceramics is a company that specializes in the design, development, and manufacturing of orthobiologic calcium phosphates. Its product range includes hydroxyapatite, α-TCP, β-TCP, and Biphasic HA and TCP, which are utilized across various medical technology and life sciences applications. The company offers a variety of products such as coating powders, specialty powders, granules, blocks, excipients, and customized solutions. By adhering to documented quality management systems, CAM Bioceramics supports clients in the orthopedic, dental, and aesthetic sectors, enabling them to enhance patient outcomes while meeting regulatory requirements.

MESI is a company focused on enhancing medical assessments in ambulatory healthcare settings through innovative technology. Its flagship product, the MESI mTABLET, is an FDA and CE marked predictive medical assessment platform that leverages artificial intelligence to streamline diagnostics for clinicians. The company specializes in developing devices that simplify the diagnostic process in primary care, enabling earlier disease detection. One of its notable offerings is an ankle-brachial pressure index measuring device, which employs the oscillometric method to screen for peripheral artery disease in older patients. By providing healthcare professionals with tools that improve efficiency and accuracy in patient assessments, MESI aims to contribute to better healthcare outcomes.

Simulands is a company dedicated to enhancing patient outcomes through advanced simulation-based medical training. The business specializes in developing and commercializing innovative simulation systems designed for healthcare education. Simulands' solutions are notable for being more practical, cost-effective, and ethical compared to traditional training methods. The company leverages expertise in medical device development and novel manufacturing techniques to create simulators that closely mimic human cardiovascular systems. This approach provides a viable alternative to animal research, aligning with the standards set by various regulatory authorities, ethics committees, and notified bodies.

Dr.Dropin is a modern private healthcare service that aims to make medical care accessible and affordable. The company operates a comprehensive digital platform that offers a wide array of medical services, including general medicine, specialist consultations, dermatology, physical therapy, and psychological support. By providing a one-stop shop for various healthcare needs, Dr.Dropin enables patients to access essential services both physically and digitally. The platform is designed to democratize the private healthcare market, ensuring that patients can receive timely care at fixed prices, thereby enhancing the overall patient experience.

PathoQuest SAS, a spin-off from Institut Pasteur, is a biotechnology company specializing in advanced pathogen detection through metagenomics. The company employs next-generation sequencing (NGS) based testing to provide actionable reports for clinicians, biologists, and quality assurance managers in the biopharmaceutical industry. PathoQuest's proprietary sample preparation methods and extensive database of pathogen genomic information address current limitations in infectious agent detection. Their Viral Safety testing service, aimed at biopharmaceutical companies, has already generated revenue from several major firms, showcasing the company’s innovative approach to molecular diagnostics.

Incision is a developer of a medical education platform designed to provide a standardized approach to performing medical procedures through a series of practical steps and sub-steps. The platform facilitates access to shared experiences, skills, and expertise, enabling medical students to achieve rapid and thorough preparation for their roles in the operating room. By focusing on the development of essential competencies and skills, Incision aims to enhance the training of future healthcare professionals.

Salvia BioElectronics B.V., founded in 2017 and based in Eindhoven, the Netherlands, specializes in developing bioelectronic therapies aimed at alleviating chronic neurological diseases, particularly chronic migraines. The company seeks to deliver innovative, drug-free solutions that restore health while minimizing side effects. The name "Salvia," derived from the Latin word for health, reflects the company's commitment to well-being, paralleling the historical use of the Salvia plant in treating ailments like headaches and mental disorders. Salvia BioElectronics is driven by a team of experienced professionals from diverse backgrounds in the medical device industry, including notable companies such as Medtronic and Philips, who collaborate to make effective bioelectronic treatments widely accessible.

Neuro Event Labs Oy, established in 2015 and headquartered in Tampere, Finland, specializes in developing artificial intelligence-based software for epilepsy patient monitoring. Their primary product collects accurate seizure data from patients at home and in hospitals, which is then analyzed and relayed to physicians for informed treatment decisions. This solution was developed in close collaboration with leading Finnish hospitals.

Blazejewski MEDI-TECH GmbH, founded in 1991 and located in Emmendingen, Germany, specializes in the development, manufacturing, and distribution of private label medical endoscopes and visualization units designed for minimally invasive and surgical applications. The company provides a broad range of products, including rigid and semi-rigid endoscopes, 3D stereoscopy systems, and custom endoscopes tailored to meet specific requirements. Their offerings encompass medical precision instruments with mechanical, electronic, and fiber optical components suitable for various medical fields such as neurology, spine, ENT, urology, and gynecology. Blazejewski MEDI-TECH serves both original equipment manufacturers in Germany and international markets, distinguishing itself as a reputable supplier in the medical technology sector.

Selfapy GmbH is a Berlin-based company that specializes in developing online therapy programs designed to assist individuals affected by mental health issues, particularly depression. Founded in 2016, Selfapy provides a range of therapy-related programs addressing anxiety, stress, eating disorders, and chronic panic, among others. The company’s offerings include three-month therapy solutions delivered via phone or SMS, featuring exercises, videos, and texts to guide users through their mental health journeys. By combining anonymity with flexibility, Selfapy aims to help users recognize negative thought patterns and develop healthier behaviors, all while having a personal psychologist as a companion in their self-help experience.

Single Use Support GmbH, founded in 2015 and headquartered in Kufstein, Austria, specializes in the manufacturing of heavy-duty single-use plastic containers and packaging products designed for the transportation of liquids, particularly in the pharmaceuticals and biopharma sectors. The company develops innovative bulk filling systems, including BULK.STREAM and RoSS.FILL, to enhance fluid logistics processes and minimize the risk of leakage or bio-contamination. By providing tailored packaging solutions, Single Use Support aims to improve the efficiency and safety of liquid transport, addressing the specific needs of its clients in the pharmaceutical industry.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in the development of innovative molecular diagnostic devices for detecting and analyzing DNA. The company utilizes its proprietary Pulse Controlled Amplification technology to enhance nucleic acid amplification and detection, featuring rapid heating and cooling rates. This advancement allows laboratories to efficiently diagnose and amplify human pathogens and DNA, simplifying the molecular testing process. GNA Biosolutions aims to make the power of molecular testing accessible to a broader audience, facilitating both laboratory and on-site applications, as well as Point of Care solutions.

Betterguards Technology GmbH specializes in innovative injury prevention solutions, particularly focusing on ankle stabilization. Founded in 2011 and headquartered in Berlin, Germany, the company designs adaptors that can be integrated into various footwear and protective gear, including sports shoes, work shoes, gloves, and orthotic devices. These adaptors aim to provide responsive support to athletes and individuals at risk of ankle injuries, such as those engaged in sports like football, basketball, skiing, and more. Betterguards' technology is engineered to protect against sudden ankle twisting or rolling while allowing a full range of motion, thus enhancing performance and reducing injury risk. The company has also developed products for therapeutic applications, catering to individuals with unstable ankles and the elderly, who may experience balance issues.

Evitria AG is a biotechnology company based in Schlieren, Switzerland, specializing in the research and development of protein design and expression products. Founded in 2010, Evitria primarily focuses on CHO-based transient expression of antibodies, including bispecific and fusion antibodies. The company has developed a robust protein expression platform that allows for the rapid production of significant quantities of protein in HEK293 and CHO cells, facilitating adeno-associated virus and lentivirus-mediated gene transfer. With a proven track record of over 30,000 transfections and 5,000 antibodies expressed and purified for a diverse clientele ranging from academic laboratories to global biopharmaceutical companies, Evitria offers a comprehensive suite of services, including custom monoclonal antibodies and gene expression services, to meet the needs of its clients efficiently and effectively.

Miracor Medical is a medical device company that specializes in developing clinical devices aimed at treating severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company is known for its PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion technology. This innovative system is designed to assist cardiac surgeons in treating patients experiencing myocardial infarction during coronary artery bypass grafting procedures. By enhancing microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size, improve cardiac function, and potentially decrease the likelihood of heart failure following acute myocardial infarction.

CoreMedic develops innovative devices for treating heart valve diseases. Its flagship product is ChordArt, a minimally invasive mitral valve repair system that addresses regurgitation by replacing or reinforcing chordae tendineae via a trans-femoral approach at the beating heart.

Medigroba GmbH is a healthcare service provider based in Germany that specializes in the care of patients across various settings, including hospitals, nursing facilities, and home environments. The company offers a range of auxiliary and care products designed for clinics, care facilities, nursing homes, and medical practices. Its product lineup includes medical care supplies, medical devices, and medical technology, complemented by the expertise of registered nurses and specialized technicians. Medigroba aims to enhance patient care and support healthcare providers with essential resources and services.

Miracor Medical is a medical device company that specializes in developing clinical devices aimed at treating severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company is known for its PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion technology. This innovative system is designed to assist cardiac surgeons in treating patients experiencing myocardial infarction during coronary artery bypass grafting procedures. By enhancing microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size, improve cardiac function, and potentially decrease the likelihood of heart failure following acute myocardial infarction.

Emerging Implant Technologies is a company specializing in the design and manufacture of orthopedic implants, particularly in the spinal sector. Founded in 2014 and headquartered in Tuttlingen, Germany, the company focuses on creating innovative products such as cervical, PLIF, and TLIF cages using advanced additive manufacturing techniques, including three-dimensional printing. This technology facilitates bone growth after fusion surgeries and aims to reduce complication rates, thereby improving treatment outcomes for patients. As of September 12, 2018, Emerging Implant Technologies operates as a subsidiary of Johnson & Johnson Medical, reflecting its commitment to advancing orthopedic care through cutting-edge implant solutions.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

Tyromotion GmbH is a manufacturer and distributor of robotic-assisted and computer-aided therapy units, specializing in rehabilitation technologies that incorporate mechatronic systems. Founded in 2007 and headquartered in Graz, Austria, with an additional office in New York City, the company focuses on the development of the Amadeo System, a mechatronic rehabilitation device designed for patients with motor dysfunctions in the distal upper extremity. Tyromotion also offers a range of devices utilizing virtual reality and gamification to enhance rehabilitation for both upper and lower extremities affected by neurological or orthopedic conditions, ultimately aiming to improve users' independence and quality of life.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Puracon is a specialized provider of medical packaging and logistics services based in Rosenheim, Germany. Established in 2003, the company focuses on delivering a comprehensive range of solutions for the medical technology, pharmacology, and biotechnology sectors. Its offerings include contract packaging services such as inspection, cleaning, assembling, packaging, sterilization, and validation of medical products. In addition, Puracon provides logistics services encompassing full-service storage and shipping. The company also offers consulting services aimed at supporting clients with product approvals. By emphasizing sterile packaging solutions and compliance with safety standards, Puracon assists clients in demonstrating the conformity and efficacy of their medical devices. As a subsidiary of KLINGEL medical metal GmbH, Puracon continues to enhance its capabilities within the industry.

SIS SCHWAGER Group through its subsidiaries develops, produces, and sells products for the treatment of vascular disease. It began operation in 2005, with its headquarters in Winterthur in Switzerland.

ndd Medizintechnik AG is a Swiss company based in Zurich that specializes in the manufacture of pulmonary function testing products. Founded in 1992, it offers a range of innovative spirometry solutions, including the EasyOne World spirometer, a portable device for lung function testing, and the EasyOne Pro LAB, which provides comprehensive spirometry along with single-breath carbon monoxide diffusion and multi-breath nitrogen washout capabilities. The company also produces the EasyOne Pro for spirometry and diffusion testing, the EasyOne-Line for direct connectivity to PCs, and the Easy on-PC for PC-based spirometry. Additionally, ndd Medizintechnik supplies various accessories, such as disposable spirettes and barriers, to enhance its product offerings. The company distributes its products through dealers in Switzerland and internationally, as well as via online platforms.

Novo Klinik-Service GmbH is a company based in Kerpen, Germany, that specializes in the development and production of fixations and pads for the intensive care, anesthetic, and nursing sectors, both domestically and internationally. The company provides a range of products, including tracheostomy and laryngectomy fixations and accessories, ventilation fixations and accessories, securement devices, and prophylactic solutions. Additionally, it offers the Novobil One, an ultra-light trolley designed to fit in various elevators, and ITS-Novo, a modular patient room specifically for intensive care settings. Established in 1987, Novo Klinik-Service has built a reputation for innovation and quality in medical equipment.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in the development of innovative molecular diagnostic devices for detecting and analyzing DNA. The company utilizes its proprietary Pulse Controlled Amplification technology to enhance nucleic acid amplification and detection, featuring rapid heating and cooling rates. This advancement allows laboratories to efficiently diagnose and amplify human pathogens and DNA, simplifying the molecular testing process. GNA Biosolutions aims to make the power of molecular testing accessible to a broader audience, facilitating both laboratory and on-site applications, as well as Point of Care solutions.

SAS Délices des 7 Vallées is a company engaged in the production of frozen cakes and pastries, specializing in high-quality patisserie products. Founded in 1996 and headquartered in Tincques, France, it has established a reputation for delivering a diverse range of frozen desserts. As of December 2018, SAS Délices des 7 Vallées operates as a subsidiary of Mademoiselle Desserts SAS, further enhancing its market presence and product offerings.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Miracor Medical is a medical device company that specializes in developing clinical devices aimed at treating severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company is known for its PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion technology. This innovative system is designed to assist cardiac surgeons in treating patients experiencing myocardial infarction during coronary artery bypass grafting procedures. By enhancing microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size, improve cardiac function, and potentially decrease the likelihood of heart failure following acute myocardial infarction.

Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters aimed at treating heart diseases, particularly atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. In addition to its product offerings, Vimecon provides advisory services to various clients in both academic and industrial research and development. Through its innovative solutions, the company aims to enhance healthcare outcomes in the treatment of cardiovascular diseases and cardiac arrhythmias.

TRI Dental Implants, established on December 1, 2010, and headquartered in Baar, Switzerland, specializes in designing, developing, and manufacturing dental implant systems. Their product portfolio includes innovative solutions such as the soft tissue concept, bone adaptation surfaces like friction fit and sandblasted, large grit, acid-etched (SBA), along with specialized lines like vent implants, narrow implants, octa implants, prosthetic components, and surgical kits for surgeons. TRI Dental Implants serves customers globally through a network of distributors in over 20 countries and direct sales in select European markets. They also facilitate online ordering for customer convenience. The company's unique touchless delivery concept enables dentists to efficiently provide tooth-fixing services, enhancing patient care.

Miracor Medical is a medical device company that specializes in developing clinical devices aimed at treating severe cardiac diseases. Founded in 2008 and headquartered in Awans, Belgium, the company is known for its PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion technology. This innovative system is designed to assist cardiac surgeons in treating patients experiencing myocardial infarction during coronary artery bypass grafting procedures. By enhancing microvascular perfusion through the coronary sinus, the PiCSO Impulse System aims to reduce infarct size, improve cardiac function, and potentially decrease the likelihood of heart failure following acute myocardial infarction.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Founded in 1986, Spiegelberg specializes in the development, production, and distribution of neurosurgical catheters and probes for brain applications. Its portfolio also includes antimicrobial products aimed at preventing hospital-acquired infections.

Phenox is a medical technology company specializing in the development and production of neuroradiological and radiological products aimed at treating neurovascular diseases. Founded in 2005 and headquartered in Bochum, Germany, the company offers a range of innovative instruments for the management of acute ischemic strokes and aneurysms. Its product portfolio includes devices such as the PCR, a miniature instrument that restores blood flow in affected brain arteries, and the CRC, a mechanical thrombectomy system. Additionally, Phenox provides specialized implants for hemorrhagic strokes and aneurysms, including flow diverters and steerable guidewires. The company is committed to enhancing patient safety through advanced hydrophilic polymer coating technology, which reduces thrombogenicity on implant surfaces. Phenox distributes its products both domestically and internationally, contributing to the global landscape of neurovascular intervention.

TNI medical AG is a company that develops, produces, and markets diagnostic and therapeutic equipment specifically for respiratory assistance therapy. Founded in 2007 and headquartered in Würzburg, Germany, the company specializes in its flagship product, the TNI SoftFlow System, which aims to enhance patient comfort by providing comprehensive respiratory support. In addition to the SoftFlow System, TNI medical offers a range of products, including breathing masks, air humidifiers, and accessories designed to optimize breathing therapy. The company operates through its facilities in Würzburg, Dessau, and Baltimore, focusing on delivering effective respiratory solutions to improve patient care. As of March 2020, TNI medical AG operates as a subsidiary of Masimo Corporation.

numares AG is a German company that specializes in developing and marketing software-based test systems for clinical diagnostics and life science research. Founded in 2004 and headquartered in Regensburg, the company employs nuclear magnetic resonance (NMR) spectroscopy to create diagnostic tests that evaluate metabolomic networks. Its AXINON in vitro diagnostic (IVD) system produces a numeric spectrum that provides valuable insights into patients' disease statuses, assisting physicians in their evaluations. Utilizing magnetic group signaling (MGS) technology, numares focuses on diagnostics in areas such as cardiovascular diseases, nephrology, oncology, and neurology. The company is recognized as a leader in commercial NMR analytics in Europe, offering a comprehensive range of NMR-analytic services that are fast, cost-efficient, and reliable, enabling doctors to interpret complex metabolic patterns from blood and urine samples effectively.

Biontis GmbH is a company based in Geesthacht, Germany, that specializes in the development of automated processes for biochemical analysis of complex liquid mixtures. Founded in 2002, Biontis produces a range of laboratory equipment and analytical procedures, including complete test kits, SPE columns, reagents, and devices designed to automate various analytical processes. Its products are utilized in diverse applications such as water analysis, food inspections, forensic medicine, and clinical diagnostics. By automating treatment steps like evaporation, heating, and dissolution, Biontis enables researchers to conduct innovative and cost-effective analytics, ensuring high-quality results in laboratory settings. The company primarily markets its offerings within Germany.

c-LEcta GmbH is a biotechnology company established in 2004 and headquartered in Leipzig, Germany. The company specializes in enzyme engineering and bioprocess development, primarily serving regulated markets such as food and pharmaceuticals. c-LEcta focuses on the development, manufacture, and commercialization of application-oriented enzyme variants, which are offered either as proprietary products or through collaborative development with industry partners. Among its key products are DENARASE, a genetically engineered endonuclease designed for the quantitative removal of nucleic acids and viscosity reduction, and CalB Immo Plus, a hydrophobic immobilized CalB preparation. The company aims to provide customized enzymes and microbial strains for various industrial applications, supporting clients in making new discoveries and enhancing market penetration through cost-efficient and sustainable production processes.

Micropelt is a startup that evolved from a collaboration between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Freiburg, Germany. The company specializes in the development of thin film thermoelectric components, leveraging semiconductor manufacturing processes to create energy harvesting systems. These systems are designed to power micro-actuators and sensors, focusing specifically on thermoelectric cooling chips and thermogenerators. Micropelt's products are utilized in various applications, including chip spot cooling, biomedical devices, heating, ventilation, air-conditioning systems, and optical sensors. Their innovative technology aims to enhance temperature management in individual rooms while contributing to CO2 reduction and improving overall user comfort.

CryLaS Crystal Laser Systems GmbH is a manufacturer based in Berlin, Germany, specializing in diode-pumped solid-state lasers across the ultraviolet (UV), visible (VIS), and infrared (IR) spectrum. Founded in 2004, the company designs its lasers for various applications, including spectroscopy, environmental technology, analysis, and photolithography. CryLaS offers both pulsed and continuous-wave laser systems that are known for their reliability, compact design, and cost-effectiveness. Its products serve diverse sectors such as biotechnology, analytics, imaging, sensor systems, and micromachining. The company distributes its products through a network that spans multiple countries, including Germany, Austria, Switzerland, the United States, Canada, and several nations across Europe, Asia, and South America.

Salvia BioElectronics B.V., founded in 2017 and based in Eindhoven, the Netherlands, specializes in developing bioelectronic therapies aimed at alleviating chronic neurological diseases, particularly chronic migraines. The company seeks to deliver innovative, drug-free solutions that restore health while minimizing side effects. The name "Salvia," derived from the Latin word for health, reflects the company's commitment to well-being, paralleling the historical use of the Salvia plant in treating ailments like headaches and mental disorders. Salvia BioElectronics is driven by a team of experienced professionals from diverse backgrounds in the medical device industry, including notable companies such as Medtronic and Philips, who collaborate to make effective bioelectronic treatments widely accessible.